Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Debjit Chattopadhyay is an analyst at Guggenheim. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/07/2024
Buy Now | Get Alert | ||||||||
---|---|---|---|---|---|---|---|---|---|
06/28/2024 | CRSP | Buy Now | CRISPR Therapeutics | $53.65 | — | — | Assumes | → Neutral | Get Alert |
05/14/2024 | FOLD | Buy Now | Amicus Therapeutics | $10.17 | 27.83% | → $13 | Upgrade | Neutral → Buy | Get Alert |
04/30/2024 | DTIL | Buy Now | Precision BioSciences | $9.40 | 102.13% | → $19 | Initiates | → Buy | Get Alert |
04/18/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $481.89 | -6.62% | $445 → $450 | Maintains | Buy | Get Alert |
03/26/2024 | VYGR | Buy Now | Voyager Therapeutics | $7.41 | 196.9% | → $22 | Initiates | → Buy | Get Alert |
03/07/2024 | DYN | Buy Now | Dyne Therapeutics | $33.61 | 10.09% | $33 → $37 | Maintains | Buy | Get Alert |
03/05/2024 | PRME | Buy Now | Prime Medicine | $5.52 | 262.32% | $24 → $20 | Maintains | Buy | Get Alert |
02/27/2024 | KRYS | Buy Now | Krystal Biotech | $191.29 | -8.52% | $130 → $175 | Maintains | Buy | Get Alert |
01/18/2024 | NAMS | Buy Now | NewAmsterdam Pharma | $20.00 | 50% | → $30 | Initiates | → Buy | Get Alert |
11/21/2023 | SLNO | Buy Now | Soleno Therapeutics | $42.41 | -5.68% | → $40 | Assumes | → Buy | Get Alert |
09/13/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $82.68 | 33.04% | → $110 | Reiterates | Buy → Buy | Get Alert |
08/15/2023 | CNTA | Buy Now | Centessa Pharmaceuticals | $9.02 | 10.86% | $9 → $10 | Maintains | Buy | Get Alert |
07/31/2023 | PRME | Buy Now | Prime Medicine | $5.52 | 334.78% | → $24 | Initiates | → Buy | Get Alert |
06/12/2023 | CNTA | Buy Now | Centessa Pharmaceuticals | $9.02 | -0.22% | → $9 | Initiates | → Buy | Get Alert |
05/22/2023 | KRYS | Buy Now | Krystal Biotech | $191.29 | -32.04% | $101 → $130 | Maintains | Buy | Get Alert |
05/02/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $481.89 | -20.11% | $339 → $385 | Maintains | Buy | Get Alert |
04/27/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $82.68 | 45.14% | $125 → $120 | Maintains | Buy | Get Alert |
02/28/2023 | QURE | Buy Now | uniQure | $3.78 | 1302.12% | → $53 | Reiterates | → Buy | Get Alert |
02/28/2023 | KRYS | Buy Now | Krystal Biotech | $191.29 | -47.2% | → $101 | Reiterates | → Buy | Get Alert |
02/28/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $82.68 | 51.19% | → $125 | Reiterates | → Buy | Get Alert |
01/26/2023 | DYN | Buy Now | Dyne Therapeutics | $33.61 | -1.81% | → $33 | Initiates | → Buy | Get Alert |
11/21/2022 | ALLO | Buy Now | Allogene Therapeutics | $2.24 | 1194.64% | $43 → $29 | Maintains | Buy | Get Alert |
11/11/2022 | PASG | Buy Now | Passage Bio | $0.93 | 1078.74% | $13 → $11 | Maintains | Buy | Get Alert |
10/13/2022 | RARE | Buy Now | Ultragenyx Pharmaceutical | $41.49 | 20.51% | → $50 | Upgrade | Neutral → Buy | Get Alert |
06/27/2022 | ALNY | Buy Now | Alnylam Pharmaceuticals | $255.11 | — | — | Downgrade | Buy → Neutral | Get Alert |
03/01/2022 | IONS | Buy Now | Ionis Pharmaceuticals | $47.24 | 35.48% | → $64 | Initiates | → Buy | Get Alert |
01/31/2022 | SRRA | Buy Now | Sierra Oncology | — | — | $35 → $51 | Maintains | Buy | Get Alert |
01/05/2022 | BEAM | Buy Now | Beam Therapeutics | $23.32 | 457.46% | → $130 | Initiates | → Buy | Get Alert |
12/16/2021 | TSHA | Buy Now | Taysha Gene Therapies | $2.22 | 1161.26% | — | Initiates | → Buy | Get Alert |
12/01/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $481.89 | -40.65% | $250 → $286 | Maintains | Buy | Get Alert |
06/01/2021 | TALS | Buy Now | Talaris Therapeutics | — | — | → $260 | Initiates | → Buy | Get Alert |
03/31/2020 | AVRO | Buy Now | Avrobio | — | — | $420 → $156 | Downgrade | Buy → Neutral | Get Alert |
03/11/2020 | DTIL | Buy Now | Precision BioSciences | $9.40 | 102.13% | $630 → $570 | Maintains | Buy | Get Alert |
09/17/2018 | AVRO | Buy Now | Avrobio | — | — | → $564 | Initiates | → Buy | Get Alert |